Currently out of the existing stock ratings of Steve Ferazani, 3 are a HOLD (42.86%), 4 are a BUY (57.14%).

Steve Ferazani

Work Performance Price Targets & Ratings Chart

Analyst Steve Ferazani, currently employed at SIDOTI, carries an average stock price target met ratio of 88.89% that have a potential upside of 18.12% achieved within 277 days.

Steve Ferazani’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Industrials sector.

Most recent stock forecast was given on SPXC, SPX Corp at 25-Feb-2025.

Wall Street Analyst Steve Ferazani

Analyst best performing recommendations are on MTX (MINERALS TECHNOLOGIES).
The best stock recommendation documented was for MTX (MINERALS TECHNOLOGIES) at 10/19/2023. The price target of $65 was fulfilled within 56 days with a profit of $12.8 (24.52%) receiving and performance score of 4.38.

Average potential price target upside

ASTE Astec Industries MTX Minerals Technologies SPXC SPX Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Jul-2018

$41

$-20.07 (-32.86%)

$40

1 years 4 months 17 days ago
(27-Feb-2025)

7/7 (100%)

$5.68 (16.08%)

544

$41

$-15.62 (-27.59%)

$40

1 years 4 months 17 days ago
(26-Feb-2025)

7/12 (58.33%)

$5.68 (16.08%)

279

Buy Since 06-May-2021

$37

2 years 2 months 12 days ago
(02-May-2024)

9/11 (81.82%)

$4.1 (12.46%)

503

Buy Since 08-Nov-2021

$62

$0.78 (1.27%)

2 years 11 months 11 days ago
(03-Aug-2023)

2/3 (66.67%)

$11.33 (22.36%)

497

Hold Since 23-Apr-2020

$41

$-20.22 (-33.03%)

$53

6 years 2 months 21 days ago
(23-Apr-2020)

2/2 (100%)

$7.11 (20.98%)

168

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Steve Ferazani?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?